Search | Search by Center | Search by Source | Keywords in Title
Li G, Crowley MJ, Tang H, Yang JY, Sandler RS, Wang T. Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials. Diabetes Care. 2019 Jul 1; 42(7):e119-e121.